Nikki J
Moderator
- Joined
- Mar 22, 2012
- Messages
- 17,828
- Reason
- PALS
- Diagnosis
- 04/2014
- Country
- US
- State
- MA
- City
- Boston
The FDA is apparently going to review the existing data It is far from a sure thing but hopeful indeed. Advocacy matters and if it gets approved credit to all but especially Brian Wallach and wife Sandra
www.statnews.com

Amylyx Pharmaceuticals Announces Plan to Submit New Drug Application (NDA) for AMX0035 for the Treatment of ALS in the Coming Months
Amylyx today announced its intention to submit a New Drug Application (NDA) to the U.S. FDA for AMX0035 for the treatment of ALS.
www.businesswire.com

Facing pressure from ALS patients and advocates, the FDA does about-face on review of potential treatment
The FDA has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a major victory for ALS patients and advocates.

Last edited: